Clinical trial
Evaluate the Efficacy and Safety of One Course of Amevive in Taiwan Patients
NCT00422617 · Uni-Pharma, Industry · Completed
Key facts
| NCT number | NCT00422617 |
|---|---|
| Title | Evaluate the Efficacy and Safety of One Course of Amevive in Taiwan Patients |
| Lead sponsor | Uni-Pharma, Industry |
| Collaborators | Biogen Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Chronic Plaque Psoriasis |
| Intervention type | Drug |
| Interventions | Alefacept (Amevive) |
| Enrollment | 40 |
| Start date | Jan 1, 2005 |
| Completion | Nov 1, 2005 |
| First posted | Jan 17, 2007 |
| Last update posted | Jan 17, 2007 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: